Antibody-negative Goodpasture's disease

NDT Plus

Volumn 3, Issue 3, 2010, Pages 253-256

  Stolk, Mordecai ^a   Carl, Daniel ^a   Massey, H Davis ^b  

^a Division of Nephrology   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

glomerulonephritis; Goodpasture's disease; immunology; kidney biopsy

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DIALYSIS; DRUG DOSE REDUCTION; GLOMERULUS; GOODPASTURE SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY NECROSIS; LOW DRUG DOSE; MALE; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEINURIA;

EID: 77955946682     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq003     Document Type: Article

References (32)

1. Lemmick HH, Schröder CH, Monnens LA et al. The clinical spectrum of type IV collagen mutations. Human Mutations 1997; 9: 477-499
2. McCoy RC, John HK, Stone WJ et al. Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 1982; 21: 642-652
3. Levy JB, Turner AN, Rees AJ et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;1033-1042
4. Daly C, Conlon PJ, Medwar Wet al. Characteristics and outcome of anti-glomerular basement membrane disease: a single center experience. Renal Failure 1996; 18: 105-112
5. Herody M, Bobrie G, Gourain C et al. Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol 1993; 40: 249-255
6. Wilson CB, Dixon FJ. Diagnosis of immunopathologic renal disease. Kidney Int 1974; 5: 389-401
7. Sinico RA, Radice A, Corace C et al. Anti-glomerular basement membrane antibodies in the diagnosis of Goodpastures syndrome: a comparison of different assays. Nephro Dia Transplant 2006; 21: 397-401
8. Hellmark T, Burkhardt H, Weislander J. Goodpasture disease: characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999; 274: 25862-25868
9. Netzer KO, Leinonen A, Boutard A et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 1999; 274: 11267-11274
10. Borza DB, Netzer KO, Leinonen A et al. The Goodpasture autoantigen: identification of multiple cryptic chain. J Biol Chem 2000; 275: 6030-6037
11. Yang R, Hellmark T, Zhao J et al. Antigen and epitope specificity of anti-glomerular basement antibodies in patients with goodpasture cytoplasmic antibodies. J Am Soc Nephrol 2007; 18: 1338-1343
12. ODonoughe DJ, Short CD, Brenchley PEC et al. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic membrane disease. Clin Nephrol 1989; 32: 251-255
13. Jayne DRW, Marshall PD, Jones SJ et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990; 37: 965-970
14. Weber MFA, Andrassy K, Pullig O et al. Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies in Goodpastures syndrome and in Wegeners granulomatosis. J Am Soc Nephrol 1992; 2: 1227-1234
15. Hellmark T, Niles JL, Collins AB et al. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997; 8: 376-385
16. Salama AD et al. Goodpastures disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 2002; 39: 1162-1167
17. Shaer AJ, Stewart LR, Cheek DE et al. IgA antiglomerular basement membrane nephritis associated with Crohns disease: a case report and review of glomerulonephritis in inflammatory bowel disease. Am J Kidney Dis 2003; 41: 1097-1109
18. Dean EG, Wilson GRA, Li M et al. Experimental autoimmune Goodpastures disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int 2005; 67: 566-575
19. Robertson J, Wu J, Arends J et al. Characteriztion of the T-cell epitope that causes anti-GBM glomerulonephritis. Kidney Int 2005; 68: 1061-1070
20. Wu J, Hicks J, Borillo J et al. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109: 517-524
21. Hellmark T, Johansson C, Wieslander J. Characteriztion of anti-GBM antibodies involved in Goodpastures syndrome. Kidney Int 1994; 46: 823-829
22. Yang RY, Cui Z, Hellmark T et al. Natural anti-GBM antibodies from normal human sera recognize-3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immun 2007; 124: 207-212
23. Aasarod K, Iversen BM, Hammerstrom J et al. Wegeners granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000; 15: 611-618
24. Geffriaud-Ricouard C, Noël LH, Chauveau D et al. Clinical spectrum associated with antineutrophil cytoplasmic antibodies of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125
25. Bosch X, Mirapeix E, Font J et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991; 36: 107-113
26. Segelmark M, Hammad T, Wieslander J. The prognostic significance in Goodpastures disease of specificity, titer, and affinity of anti-glomerular basement membrane antibodies. Nephron Clin Pract 2003; 94: c59-c68
27. Levy JB, Hammad T, Coulthart A et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004; 66: 1535-1540
28. Rutgers A, Slot M, van Paasen P et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005; 46: 253-262
29. Hogan SL, Falk RJ, Chin H et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated smallvessel vasculitis. Annals of Int Med 2005; 143: 621-631
30. Nachman PH, Segelmark M, Westman K et al. ANCA-associated small vessel vasculitis after transplantation. Kidney Int 1999; 56: 1544-1550
31. Levy JB, Lachmann RH, Pusey CD. Recurrent Goodpastures disease. Am J Kidney Dis 1996; 27: 573-578
32. Khandelwal M, McCormick BB, Lajoie G et al. Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 2004; 19: 491-494